Neurocrine Bio. (NBIX) Jumps on New "Overweight" Rating at Morgan Stanley
Tweet Send to a Friend
Neurocrine Bio. (NASDAQ: NBIX) is 4 percent higher Thursday after Morgan Stanley initiated coverage on the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
